Abstract
Ordinarily, β-adrenergic receptors and responses linked to the receptors increase with development but in the liver, β-receptors are higher in the fetus and neonate than in adulthood. We examined how hepaticβ-receptor signaling mediated through adenylyl cyclase is regulated in rats of different ages. In each case, animals were pretreated with isoproterenol for 4 d, and on the 5th d, hepatic membrane preparations were examined for adenylyl cyclase activity and receptor binding capabilities. Uniquely in 6-d-old animals, the cyclase response to isoproterenol was enhanced by chronic pretreatment, caused by heterologous sensitization mediated through effects on total catalytic activity (increased response to forskolin-Mn2+) and on G-protein coupling (enhanced effect of fluoride and increased GTP dependence of basal activity). Isoproterenol pretreatment failed to cause β-receptor down-regulation in 6-d-old animals, but by 15 d of age, down-regulation was detected along with slight desensitization of the cyclase response. However, at 25 d, neither effect was present. In adulthood, repeated isoproterenol administration failed to cause cyclase desensitization but did reduce β-receptor numbers; the loss of receptors was still unusual in that β-receptor down-regulation could be achieved with either isoproterenol or with methoxamine, an α-receptor agonist. The results indicate that, early in development, hepaticβ-receptor-mediated responses are enhanced, not desensitized, after chronic stimulation. These effects would foster responsiveness of hepatic gluconeogenesis in the face of the massive adrenergic stimulation associated with the transition from fetal to neonatal life. In adulthood, when receptor numbers are far lower than in the neonate, the inability to desensitize the signaling cascade despite receptor down-regulation would serve to maintain the response to catecholamines.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ANOVA:
-
analysis of variance
References
Lagercrantz H, Slotkin TA 1986 The stress of being born. Sci Am 254: 100–107.
Lautt WW 1979 Autonomic control of liver glycogen metabolism. Med Hypotheses 5: 1287–1296.
Ali M, Cantau B, Clos J 1989 Glycogenolytic responsiveness to glucagon, epinephrine, vasopressin and angiotensin II in the liver of developing hypothyroid rats. A comparative study of in vitro hormonal binding and in vivo biological response. J Dev Physiol 11: 360–367.
Duée PH, Pégorier JP, El Manoubi L, Ferré P, Bois-Joyeux B, Girard J 1986 Development of gluconeogenesis from different substrates in newborn rabbit hepatocytes. J Dev Physiol 8: 387–394.
McMillian MK, Schanberg SM, Kuhn CM 1983 Ontogeny of rat hepatic adrenoceptors. J Pharmacol Exp Ther 227: 181–186.
Huff RA, Seidler FJ, Slotkin TA 1991 Glucocorticoids regulate the ontogenetic transition of adrenergic receptor subtypes in rat liver. Life Sci 48: 1059–1066.
Lagercrantz H, Bistoletti P 1973 Catecholamine release in the newborn infant at birth. Pediatr Res 11: 889–893.
Slotkin TA, Seidler FJ 1988 Adrenomedullary catecholamine release in the fetus and newborn: secretory mechanisms and their role in stress and survival. J Dev Physiol 10: 1–16.
Slotkin TA 1986 Endocrine control of synaptic development in the sympathetic nervous system the cardiac-sympathetic axis. In: Gootman PM (ed) Developmental Neurobiology of the Autonomic Nervous System. Humana Press, Clifton, NJ, 97–133.
Slotkin TA 1986 Development of the sympathoadrenal axis. In: Gootman PM (ed) Developmental Neurobiology of the Autonomic Nervous System. Humana Press, Clifton, NJ, 69–96.
Morgan NG, Blackmore PF, Exton JH 1983 Age-related changes in the control of hepatic cyclic AMP levels by 1 and2 adrenergic receptors. J Biol Chem 258: 5103–5109.
Minneman KP, Pittman RN, Molinoff PB 1981 1981βAdrenergic receptor subtypes: properties, distribution, and regulation. Ann Rev Neurosci 4: 419–461.
Weiss ER, Kelleher DJ, Woon CW, Soparkar S, Osawa S, Heasley LE, Johnson GL 1988 Receptor activation of G proteins. FASEB J 2: 2841–2848.
Stiles GL 1989 Mechanisms of receptor activation in adenylate cyclase. J Cardiovasc Pharmacol 14:S1–S5.
Yamada S, Yamamura HI, Roeske WR 1986 Effects of chemical sympathectomy with 6-hydoxydopamine on - and-adrenoceptors and muscarinic cholinoceptors in rat kidney. Eur J Pharmacol 121: 345–353.
Pointon SE, Banerjee SP 1979 Alpha- and beta-adrenergic receptors of the rat salivary gland: elevation after chemical sympathectomy. Biochim Biophys Acta 584: 231–241.
Yamada S, Yamamura HI, Roeske WR 1980 Alterations in cardiac autonomic receptors following 6-hydroxydopamine. Mol Pharmacol 18: 185–192.
Lau C, Burke SP, Slotkin TA 1982 Maturation of sympathetic neurotransmission in the rat heart. IX. Development of transsynaptic regulation of cardiac adrenergic sensitivity. J Pharmacol Exp Ther 223: 675–680.
Maisel AS, Motulsky JJ, Insel PA 1987 Life cycles of cardiac α1- and β-adrenergic receptors. Biochem Pharmacol 36: 1–6.
Minneman KP 1988 α1-Adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacol Rev 40: 87–119.
Premont RT, Jacobowitz O, Iyengar R 1992 Lowered responsiveness of the catalyst of adenylyl cyclase to stimulation by Gs in heterologous desensitization: a role for adenosine 3′,5′-monophosphate-dependent phosphorylation. Endocrinology 131: 2774–2784.
Clark RB, Friedman J, Dixon RA, Strader CD 1989 Identification of a specific site required for rapid heterologous desensitization of the β-adrenergic receptor by cAMP-dependent protein kinase. Mol Pharmacol 36: 343–348.
Yamashita A, Kurokawa T, Une Y, Ishibashi S 1989 Reduction in the stability of the Gs-catalytic unit complex of adenylate cyclase in isoproterenol-induced heterologous desensitization. Eur J Pharmacol 159: 247–256.
Ping PP, Gelzer-Bell R, Roth DA, Kiel D, Insel PA, Hammond HK 1995 Reduced β-adrenergic receptor activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart. J Clin Invest 95: 1271–1280.
Seamon K, Daly JW 1981 Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem 256: 9799–9801.
Seamon KB, Daly JW 1986 Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res 20: 1–150.
Chaudhry A, Granneman JG 1991 Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Am J Physiol 261:R403–R411.
Chaudhry A, Granneman JG 1992 Adrenergic regulation of neonatal brown fat adenylyl cyclase and Gsα activity. Am J Physiol 263:R34–R38.
Seidler FJ, Slotkin TA 1979 Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the preweanling rat. Br J Pharmacol 65: 431–434.
Mills E, Smith PG 1986 Mechanisms of adrenergic control of blood pressure in developing rats. Am J Physiol 250:R188–R192.
Hou Q-C, Seidler FJ, Slotkin TA 1989 Development of the linkage of β-adrenergic receptors to cardiac hypertrophy and heart rate control: neonatal sympathectomy with 6-hydroxydopamine. J Dev Physiol 11: 305–311.
Lowry OH, Rosebrough NJ, Farr AL, Randall R 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–270.
Sánchez-Capelo A, Peñafiel R, Tovar A, Galindo JD, Cremades A 1994 Postnatal development of ornithine decarboxylase and polyamines in the mouse kidney: influence of testosterone. Biol Neonate 66: 119–127.
Slotkin TA, Navarro HA, McCook EC, Seidler FJ 1990 Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci 47: 1561–1567.
Navarro HA, Kudlacz EM, Slotkin TA 1991 Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol Neonate 60: 127–136.
Slotkin TA, Kavlock RJ, Cowdery T, Orband L, Bartolome M, Whitmore WL, Bartolome J 1986 Effects of neonatal methylmercury exposure on adrenergic receptor binding sites in peripheral tissues of the developing rat. Toxicology 41: 95–106.
Snedecor GW, Cochran WG 1967 Statistical Methods. Iowa State University Press, Ames, IA, 346–349.
Giannuzzi CE, Seidler FJ, Slotkin TA 1995 β-1995-Adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res 694: 271–278.
Cros GH, Chanez PO, Michel A, Boucard M, Serrano J-J 1988 Post-natal evolution of rat cardiac β-adrenoceptors. Life Sci 43: 699–706.
Maier JA, Roberts JM, Jacobs MM 1989 Ontogeny of fetal adenylate cyclase; mechanisms for regulation of β-adrenergic receptors. J Dev Physiol 12: 249–261.
Slotkin TA, Lorber BA, McCook EC, Barnes GA, Seidler FJ 1995 Neural input and the development of adrenergic intracellular signaling: neonatal denervation evokes neither receptor up-regulation nor persistent supersensitivity of adenylate cyclase. Dev Brain Res 88: 17–29.
Seidler FJ, Slotkin TA 1981 Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine. Neuroscience 6: 2081–2086.
Smith PG, Slotkin TA, Mills E 1982 Development of sympathetic ganglionic neurotransmission in the neonatal rat. Pre- and postganglionic nerve response to asphyxia and 2-deoxyglucose. Neuroscience 7: 501–507.
Thonberg H, Zhang SJ, Tvrdik P, Jacobsson A, Nedergaard J 1994 Norepinephrine utilizes α1- and βadrenoreceptors synergistically to maximally induce c-fos expression in brown adipocytes. J Biol Chem 269: 33179–33186.
Paraschos A, Karliner JS 1994 Receptor crosstalk: effects of prolonged carbachol exposure on β1adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes. Naunyn-Schmiedebergs Arch Pharmacol 350: 267–276.
Kudlacz EM, Navarro HA, Slotkin TA 1989 Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to-adrenergic stimulation. J Pharmacol Exp Ther 250: 236–240.
Friedhoff AJ, Miller JC 1983 Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems. Monogr Neural Sci 9: 91–98.
Whitaker-Azmitia PM 1991 Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev 43: 553–561.
Hou Q-C, Baker FE, Seidler FJ, Bartolome M, Bartolome J, Slotkin TA 1989 Role of sympathetic neurons in development of-adrenergic control of ornithine decarboxylase activity in peripheral tissues: effects of neonatal 6-hydroxydopamine treatment. J Dev Physiol 11: 139–146.
Hou Q-C, Eylers JP, Lappi SE, Kavlock RJ, Slotkin TA 1989 Neonatal sympathectomy compromises development of responses of ornithine decarboxylase to hormonal stimulation in peripheral tissues. J Dev Physiol 12: 189–192.
Wagner JP, Seidler FJ, Slotkin TA 1991 Presynaptic input regulates development of -adrenergic control of rat brain ornithine decarboxylase: effects of 6-hydroxydopamine or propranolol. Brain Res Bull 26: 885–890.
Wagner JP, Seidler FJ, Lappi SE, McCook EC, Slotkin TA 1995 Role of presynaptic input in the ontogeny of adrenergic cell signaling in rat brain: receptors, adenylate cyclase, and c-fos protooncogene expression. J Pharmacol Exp Ther 273: 415–426.
Bian X-P, Seidler FJ, Slotkin TA 1992 Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to -adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol 17: 289–297.
Kawai Y, Arinze IJ 1993 Glucocorticoid regulation of G-protein subunits in neonatal liver. Mol Cell Endocrinol 90: 203–209.
Slotkin TA, McCook EC, Seidler FJ 1993 Glucocorticoids regulate the development of intracellular signaling: enhanced forebrain adenylate cyclase catalytic subunit activity after fetal dexamethasone exposure. Brain Res Bull 32: 359–364.
Slotkin TA, Lau C, McCook EC, Lappi SE, Seidler FJ 1994 Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization?. Toxicol Appl Pharmacol 127: 64–75.
Baldwin KM, Campbell PJ, Hooker AM, Lewis RE 1979 Effects of thyroid deficiency and sympathectomy on cardiac enzymes. Am J Physiol 236:C30–C34.
Pracyk JB, Slotkin TA 1991 Thyroid hormone differentially regulates development of -adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney. J Dev Physiol 16: 251–261.
Birk E, Tyndall MR, Erickson LC, Rudolph AM, Roberts JM 1992 Effects of thyroid hormone on myocardial adrenergic -receptor responsiveness and function during late gestation. Pediatr Res 31: 468–473.
Wagner JP, Seidler FJ, Lappi SE, McCook EC, Slotkin TA 1994 Role of thyroid status in the ontogeny of adrenergic cell signaling in rat brain: β receptors, adenylate cyclase, ornithine decarboxylase and c-fos protooncogene expression. J Pharmacol Exp Ther 271: 472–483.
Author information
Authors and Affiliations
Additional information
Supported by U.S. Public Health Service Grant HD-09713.
Rights and permissions
About this article
Cite this article
Thai, L., Galluzzo, J., McCook, E. et al. Atypical Regulation of Hepatic Adenylyl Cyclase and Adrenergic Receptors During a Critical Developmental Period: Agonists Evoke Supersensitivity Accompanied by Failure of Receptor Down-Regulation. Pediatr Res 39, 697–707 (1996). https://doi.org/10.1203/00006450-199604000-00023
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199604000-00023
This article is cited by
-
Adverse Neurodevelopmental Effects of Dexamethasone Modeled in PC12 Cells: Identifying the Critical Stages and Concentration Thresholds for the Targeting of Cell Acquisition, Differentiation and Viability
Neuropsychopharmacology (2006)
-
Effects of Prenatal Nicotine Exposure on Primate Brain Development and Attempted Amelioration with Supplemental Choline or Vitamin C: Neurotransmitter Receptors, Cell Signaling and Cell Development Biomarkers in Fetal Brain Regions of Rhesus Monkeys
Neuropsychopharmacology (2005)
